Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Safety and Efficacy of Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Renal Failure.

NCT00256100 is registered in ClinicalTrials.gov with Melbourne Health as lead sponsor.

NCT NCT00256100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00256100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Safety and Efficacy of Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Renal Failure.
Lead sponsor
Melbourne Health
Phase
Not applicable
Overall status
Terminated
Start date
June 30, 2004
Completion date
December 31, 2007
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal failure